Purpose: To determine whether the use of uterotonics, including oxytocin and prostaglandins, increases the risk of abruptio placentae and eclampsia.
Materials And Methods: A retrospective analysis was conducted among 260,174 Japanese women at term. Demographic characteristics were studied as possible candidates for risk factors of abruptio placentae and eclampsia using multivariate logistic regression analyses.
Results: A total of 1,058 (0.41 %) and 147 (0.06 %) women developed abruptio placentae and eclampsia, respectively. Abruptio placentae and eclampsia occurred in 177 (0.29 %) and 42 (0.07 %) of the 61,857 women treated with uterotonics, respectively. Multivariate regression analyses indicated that uterotonics did not increase risk of developing either abruptio placentae or eclampsia. Primiparity [odds ratio (95 % confidence interval) 1.41 (1.24-1.60)], age ≥35 years [1.17 (1.03-1.33)], and presence of hypertension [2.42 (1.93-3.03)] were significant independent risk factors for abruptio placentae, while advancing gestation [0.67 (0.63-0.71)] decreased risk of abruptio placentae. Primiparity [odds ratio (95 % confidence interval) 4.06 (2.49-6.63)], age <20 years [2.44 (1.07-5.58)], presence of hypertension [28.7 (20.5-40.1)], and advancing gestation [1.28 (1.11-1.47)] were significant independent risk factors for eclampsia.
Conclusion: The use of uterotonics did not increase the risk of abruptio placentae and eclampsia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00404-013-3101-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Perinatal outcomes and predictors of placental abruption: a retrospective study in an Ethiopian tertiary care center.
Front Public Health
January 2025
Department of Epidemiology, St. Peter Specialized Hospital, Addis Ababa, Ethiopia.
Background: Placental abruption is a critical obstetric condition characterized by the premature separation of the placenta from the uterus, leading to severe maternal and fetal complications. In Ethiopia, the maternal and perinatal morbidity and mortality rates are alarmingly high, and placental abruption significantly contributes to these adverse outcomes. Despite its severity, there is a lack of comprehensive data on the burden, risk factors, and outcomes associated with placental abruption in the Ethiopian context.
View Article and Find Full Text PDFPlacental Abruption: Pathophysiology, Diagnosis, and Management.
Clin Obstet Gynecol
March 2025
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, NYU Grossman Long Island School of Medicine.
Placental abruption is a complete or partial separation of the placenta from the uterine decidua. Clinical manifestations include vaginal bleeding, abdominal pain, uterine contractions, and abnormalities in the fetal heart rate tracing. Placental abruption occurs in 0.
View Article and Find Full Text PDFHypertensive disorders of pregnancy in Hunan Province, China, 2012-2022.
Front Med (Lausanne)
December 2024
Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan Province, China.
Objective: To explore the relationship between hypertensive disorders of pregnancy (HDP) and adverse pregnancy outcomes and explore the risk factors for HDP.
Methods: Data were obtained from the Maternal Near-Miss Surveillance System in Hunan Province, China, 2012-2022. Chi-square trend tests ( ) were used to determine trends in prevalence by year.
Analysis of Modified ISTH DIC Score in Cases of Abruptio Placentae and Its Correlation with Severity of Abruptio Placentae.
J Obstet Gynaecol India
December 2024
Department of Obstetrics & Gynecology, N.S.C.B Medical College, Jabalpur, M.P. India.
Background: Disseminated intravascular coagulation (DIC) is a potentially fatal condition which is always secondary to an underlying disorder with abruption being the most common cause in obstetrics.Our study analysed the modified International Society of Thrombosis and Haemostasis DIC score for prediction of DIC in cases of abruptio placentae. Additionally, we correlated the score with severity of abruption to optimize its use in limited resource settings.
View Article and Find Full Text PDFIschemic Placental Disease: Epidemiology and Impact on Maternal and Offspring Health Along the Life Course.
Clin Obstet Gynecol
March 2025
Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences.
Ischemic placental disease (IPD) is a constellation of obstetrical complications that include preeclampsia, placental abruption, and fetal growth restriction and affects 12% to 15% of pregnancies. The unifying pathophysiological mechanism that precedes all 3 complications is uteroplacental ischemia as a consequence of inadequate (or failure of) physiological transformation of the maternal uterine spiral arteries, endothelial cell dysfunction, and increased oxidative stress. This review summarizes the IPD literature, focusing on the epidemiology and risk factors, the effects of IPD on short and long-term maternal complications, and the association of IPD with perinatal, childhood, and long-term complications in offspring.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!